Antibody microarrays utilizing site-specific antibody-oligonucleotide conjugates

Area of Science:

• Biotechnology
• Molecular Biology
• Nanotechnology

Background:

• Conventional protein arrays often suffer from random protein absorption, leading to suboptimal orientation and functionality.
• Existing antibody array generation methods have inherent limitations that hinder efficiency and performance.

Purpose of the Study:

• To develop a DNA-encoded antibody microarray using site-specific antibody-oligonucleotide conjugates.
• To enable efficient cell immobilization and sensitive detection of genes and proteins.
• To overcome the drawbacks associated with traditional antibody array production.

Main Methods:

• Utilized site-specific antibody-oligonucleotide conjugates for microarray fabrication.
• Employed DNA-encoded antibody technology for antibody immobilization.
• Validated the method for capturing and detecting SK-BR-3 cells (Her2+ breast cancer cells).

Main Results:

• Achieved sensitive detection of SK-BR-3 cells down to 10(2) cells/mL without microfluidics.
• Demonstrated 100- to 10(5)-fold higher sensitivity compared to existing techniques.
• Successfully detected Her2+ cells within a complex mixture of white blood cells, highlighting specificity.

Conclusions:

• The developed DNA-encoded antibody microarray technology facilitates the generation of high-performance antibody arrays.
• This innovative approach offers a highly sensitive and specific platform for cell detection, with potential applications in early cancer diagnostics.
• The technology's sensitivity is well-suited for detecting circulating tumor cells at clinically relevant concentrations.